Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation (Journal of Hematology & Oncology, (2022), 15, 1, (109), 10.1186/s13045-022-01330-3)

Muhammad Elnaggar, Sarita Agte, Paula Restrepo, Meghana Ram, David Melnekoff, Christos Adamopoulos, Mark M. Stevens, Katerina Kappes, Violetta Leshchenko, Daniel Verina, Sundar Jagannath, Poulikos I. Poulikakos, Samir Parekh, Alessandro Laganà

Research output: Contribution to journalComment/debate

Abstract

The authors of the original article [1] mistakenly omitted a Funding source which is stated ahead: Alessandro Lagana was supported by the ASH Bridge Grant Award.

Original languageEnglish
Article number52
JournalJournal of Hematology and Oncology
Volume16
Issue number1
DOIs
StatePublished - Dec 2023

Fingerprint

Dive into the research topics of 'Correction: Triple MAPK inhibition salvaged a relapsed post-BCMA CAR-T cell therapy multiple myeloma patient with a BRAF V600E subclonal mutation (Journal of Hematology & Oncology, (2022), 15, 1, (109), 10.1186/s13045-022-01330-3)'. Together they form a unique fingerprint.

Cite this